Antimicrobial therapy in experimental pseudomonas infection. II

R. C. McDaniel, P. M. Southern

Research output: Contribution to journalArticle

Abstract

Young adult male mice were infected with recent clinical isolates of Pseudomonas aeruginosa in an experimental model of lethal pseudomonas infection. Three strains of pseudomonas, designated MS2, MZT624 and 017 were inoculated intraperitoneally to initiate infection. Mortality in untreated control animals ranged from 71 to 88%. Treated animals received carbenicillin, gentamicin, polymyxin B, and colistimethate, either singly or in various combinations. No combination of antimicrobial agents was significantly more effective than an appropriate single drug in reducing mortality in MS2 and 017 infections. MZT624 infection did not respond to single drug therapy but mortality was significantly ameliorated with the use of one 2 drug combination and two 3 drug combinations. No true in vivo synergism was observed. In several instances, an organism showed an in vitro susceptibility to an antimicrobial agent that failed to prove therapeutically effective in vivo.

Original languageEnglish (US)
Pages (from-to)375-386
Number of pages12
JournalCurrent Therapeutic Research - Clinical and Experimental
Volume16
Issue number4
StatePublished - 1974

Fingerprint

Pseudomonas Infections
Investigational Therapies
Drug Combinations
Anti-Infective Agents
Mortality
Infection
Carbenicillin
Polymyxin B
Pseudomonas
Pseudomonas aeruginosa
Young Adult
Theoretical Models
Drug Therapy
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Antimicrobial therapy in experimental pseudomonas infection. II. / McDaniel, R. C.; Southern, P. M.

In: Current Therapeutic Research - Clinical and Experimental, Vol. 16, No. 4, 1974, p. 375-386.

Research output: Contribution to journalArticle

@article{f271f02789244e6b902f2af40c69617c,
title = "Antimicrobial therapy in experimental pseudomonas infection. II",
abstract = "Young adult male mice were infected with recent clinical isolates of Pseudomonas aeruginosa in an experimental model of lethal pseudomonas infection. Three strains of pseudomonas, designated MS2, MZT624 and 017 were inoculated intraperitoneally to initiate infection. Mortality in untreated control animals ranged from 71 to 88{\%}. Treated animals received carbenicillin, gentamicin, polymyxin B, and colistimethate, either singly or in various combinations. No combination of antimicrobial agents was significantly more effective than an appropriate single drug in reducing mortality in MS2 and 017 infections. MZT624 infection did not respond to single drug therapy but mortality was significantly ameliorated with the use of one 2 drug combination and two 3 drug combinations. No true in vivo synergism was observed. In several instances, an organism showed an in vitro susceptibility to an antimicrobial agent that failed to prove therapeutically effective in vivo.",
author = "McDaniel, {R. C.} and Southern, {P. M.}",
year = "1974",
language = "English (US)",
volume = "16",
pages = "375--386",
journal = "Current Therapeutic Research - Clinical and Experimental",
issn = "0011-393X",
publisher = "Excerpta Medica",
number = "4",

}

TY - JOUR

T1 - Antimicrobial therapy in experimental pseudomonas infection. II

AU - McDaniel, R. C.

AU - Southern, P. M.

PY - 1974

Y1 - 1974

N2 - Young adult male mice were infected with recent clinical isolates of Pseudomonas aeruginosa in an experimental model of lethal pseudomonas infection. Three strains of pseudomonas, designated MS2, MZT624 and 017 were inoculated intraperitoneally to initiate infection. Mortality in untreated control animals ranged from 71 to 88%. Treated animals received carbenicillin, gentamicin, polymyxin B, and colistimethate, either singly or in various combinations. No combination of antimicrobial agents was significantly more effective than an appropriate single drug in reducing mortality in MS2 and 017 infections. MZT624 infection did not respond to single drug therapy but mortality was significantly ameliorated with the use of one 2 drug combination and two 3 drug combinations. No true in vivo synergism was observed. In several instances, an organism showed an in vitro susceptibility to an antimicrobial agent that failed to prove therapeutically effective in vivo.

AB - Young adult male mice were infected with recent clinical isolates of Pseudomonas aeruginosa in an experimental model of lethal pseudomonas infection. Three strains of pseudomonas, designated MS2, MZT624 and 017 were inoculated intraperitoneally to initiate infection. Mortality in untreated control animals ranged from 71 to 88%. Treated animals received carbenicillin, gentamicin, polymyxin B, and colistimethate, either singly or in various combinations. No combination of antimicrobial agents was significantly more effective than an appropriate single drug in reducing mortality in MS2 and 017 infections. MZT624 infection did not respond to single drug therapy but mortality was significantly ameliorated with the use of one 2 drug combination and two 3 drug combinations. No true in vivo synergism was observed. In several instances, an organism showed an in vitro susceptibility to an antimicrobial agent that failed to prove therapeutically effective in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0016154525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016154525&partnerID=8YFLogxK

M3 - Article

C2 - 4364246

AN - SCOPUS:0016154525

VL - 16

SP - 375

EP - 386

JO - Current Therapeutic Research - Clinical and Experimental

JF - Current Therapeutic Research - Clinical and Experimental

SN - 0011-393X

IS - 4

ER -